The related silyl compound, Zifrosilone, a slow tight binding inhibitor of type A with a long residence time τ = 70 h and Ki = 0.26 nM for rat brain AChE [7] was promising for symptomatic treatment of AD [7,8,10]. The gene discussed is ACHE; the disease is Alzheimer disease.